Some Products May Appear Restricted
To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.
If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/ca/en/login/register)
If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation; additional documentation will be requested for these items prior to shipment.
Specifications
- Conjugation:Unconjugated
- Protein/peptide type:Recombinant
- Source:CHO cells
- Species:Human
- Size:100 μg
- Storage conditions:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
- Endotoxin content:<0.01 EU per 1 ╡g of the protein by the LAL method.
- Gene ID:4055
- Protein synonyms:LTBR|Tumor necrosis factor C receptor|Lymphotoxin-beta receptor|TNFRSF3TNFR-III|lymphotoxin B receptor|CD18|TNFR2-RP|TNFR superfamily|Tumor necrosis factor receptor 2-related protein|tumor necrosis factor receptor superfamily member 3|TNFR-RP|TNFR3|TNF-R-III|Tumor necrosis factor receptor type III|lymphotoxin beta receptor (TNFR superfamily|member 3)|tumor necrosis factor receptor superfamily|member 3|ltbetar|LT-BETA-R|TNFRSF3|D12S370|TNFCRTNF-RIII|LymphotoxinbR|TNF Rrp|TNF RIII
- Accession no.:NP_002333
- Protein/peptide name:Lymphotoxin beta R/TNFRSF3
- Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
- Molecular weight:60-66 kDa, reducing conditions
- Cat. no.:102877-238
- Supplier No.:7538-LR-100
Specifications
About this item
The Recombinant Human LT beta R/TNFRSF3 Fc Chimera (CHO) from R&D Systems is derived from CHO. The Recombinant Human LT beta R/TNFRSF3 Fc Chimera (CHO) has been validated for the following applications: Bioactivity.